Astrana Health earnings were $62.5M for the trailing 12 months ending Sep 30, 2024, with 39.4% growth year over year. The latest ASTH earnings report on Sep 30, 2024 announced Q3 2024 earnings of $16.1M, down 16.1% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, ASTH reported annual earnings of $60.7M, with 34.4% growth. The next ASTH earnings date is Feb 25, 2025.
ASTH past earnings growth
How has ASTH's earnings growth performed historically?
On ASTH's earnings call on Invalid Date, Astrana Health (NASDAQ: ASTH) reported Q3 2024 earnings per share (EPS) of $0.34, up 27.66% year over year. Total ASTH earnings for the quarter were $16.09 million. In the same quarter last year, Astrana Health's earnings per share (EPS) was $0.47.
The next ASTH earnings date is Invalid Date. Add ASTH to your watchlist to be reminded of Astrana Health's next earnings date.
Is Astrana Health profitable or losing money?
As of the last Astrana Health earnings report, Astrana Health is currently profitable. Astrana Health's net profit (also called net income) for the twelve months ending Sep 30, 2024 was $62.46 million, a 39.93% increase year over year.
What was ASTH's earnings growth in the past year?
As of Astrana Health's earnings date in Invalid Date, Astrana Health's earnings has grown 39.36% year over year. This is 54.74 percentage points lower than the US Medical Care Facilities industry earnings growth rate of 94.1%. ASTH earnings in the past year totalled $62.46 million.
What are Astrana Health's earnings expectations?
The current EPS estimate for Astrana Health's earnings report in Invalid Date is $0.21.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.